The Business of Biofabrication

UT Southwestern Medical Center has been awarded up to $25 million from Advanced Research Projects Agency for Health (ARPA-H) to develop fully personalized, bioprinted human livers using patients’ own cells. The initiative, known as Vascularized Immunocompetent Tissue as an Alternative Liver (VITAL), is part of ARPA-H’s PRINT program and aims to address the persistent shortage…